Intrexon | XON - Actif À Court Terme





Actif À Court Terme Changement Date
Agenus USD 78.81M 16.47M 2026-06
Alaunos Therapeutics USD 970K 1.02M 2026-03
Amgen USD 34.96B 3.49B 2026-06
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Gilead Sciences USD 12.53B 6.11B 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
Heron Therapeutics USD 229.84M 861K 2026-06
Incyte USD 6.03B 542.31M 2026-06
Intrexon USD 23.72M 45.04M 2024-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Ligand Pharmaceuticals USD 1.46B 591.7M 2026-06
MacroGenics USD 321.69M 139.16M 2026-06
MannKind USD 245.71M 5.45M 2026-06
Merck USD 36.68B 1.66B 2026-06
Novartis USD 27.35B 744M 2026-06
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
Veracyte USD 574.78M 52.6M 2026-06
Xencor USD 523.21M 40.36M 2026-06